These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9455458)
1. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment]. Stefănescu C; Chossiere L; Rusu V; Meignan M Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458 [TBL] [Abstract][Full Text] [Related]
2. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma. Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092 [TBL] [Abstract][Full Text] [Related]
3. Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation. Rubini G; D'Eredità G Clin Nucl Med; 2000 Jun; 25(6):482-3. PubMed ID: 10836705 [TBL] [Abstract][Full Text] [Related]
4. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report. Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579 [TBL] [Abstract][Full Text] [Related]
5. [Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer]. Sassolas G; Houzard C; Sigartau C; Borson-Chazot F Ann Endocrinol (Paris); 1997; 58(1):55-63. PubMed ID: 9207967 [TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters]. Dimonte M; Leo G; Marsigliante S; Manca C Radiol Med; 1999 Nov; 98(5):352-5. PubMed ID: 10780214 [TBL] [Abstract][Full Text] [Related]
7. Breast parenchymal activity on scintimammography: comparison between bone-seeking agents and 99mTc-sestamibi. Inoue Y; Katayama N; Yoshioka N; Yoshikawa K; Kashima M; Shimizu T; Tsukune Y; Ohtomo K Ann Nucl Med; 1999 Dec; 13(6):453-6. PubMed ID: 10656284 [TBL] [Abstract][Full Text] [Related]
8. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma. Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581 [TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of 99mTc-methoxy-isobutyl-isonitril and 99mTc-methylene diphosphonate scintimammography in the preoperative evaluation of breast cancer]. Schmidt E; Kett K; Anga B; Bódis J; Zámbó K Orv Hetil; 2003 Apr; 144(17):787-92. PubMed ID: 12762063 [TBL] [Abstract][Full Text] [Related]
10. Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy. Yang JG; Li CL; Hao RR; Zou LF Ann Nucl Med; 2008 Jan; 22(1):79-82. PubMed ID: 18250991 [TBL] [Abstract][Full Text] [Related]
11. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours. Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180 [TBL] [Abstract][Full Text] [Related]
12. [Tumor imaging in nuclear medicine]. Uno K; Kuyama J; Uchida Y; Sakata S; Kitakata Y Nihon Rinsho; 1996 May; 54(5):1268-72. PubMed ID: 8965349 [TBL] [Abstract][Full Text] [Related]
13. Acquisition protocol for breast cancer imaging with technetium-99m-labeled synthetic peptide and technetium-99m-MDP. Fiorenza M; Prisco G; Bartolomei M; Chinol M; Cremonesi M; Leonardi L; De Cicco C; Paganelli G J Nucl Med Technol; 1997 Sep; 25(3):191-4. PubMed ID: 9291065 [TBL] [Abstract][Full Text] [Related]
14. Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results. Vural G; Unlü M; Atasever T; Ozur I; Ozdemir A; Gökçora N Eur J Nucl Med; 1997 Mar; 24(3):312-5. PubMed ID: 9143470 [TBL] [Abstract][Full Text] [Related]
15. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer. Mirzaei S; Knoll P; Lipp RW; Köhn H J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127 [No Abstract] [Full Text] [Related]
16. Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia. Pickhardt PJ; McDermott M J Nucl Med; 1997 Apr; 38(4):528-30. PubMed ID: 9098196 [TBL] [Abstract][Full Text] [Related]
17. Axillary node metastasis detection in breast cancer with 99mTc-sestaMIBI and 111In-pentetreotide. Chiti A; Maffioli LS; Agresti R; Spinelli A; Savelli G; Casteliani MR; Giovanazzi R; Greco M; Bombardieri E Tumori; 1997; 83(2):537-8. PubMed ID: 9226013 [No Abstract] [Full Text] [Related]
18. Scintimammography with 99mTc-MDP in the detection of primary breast cancer. Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130 [TBL] [Abstract][Full Text] [Related]
19. Abundant blood supply and low P-glycoprotein expression on dynamic 99mTc-MIBI imaging predicted better chemotherapy sensitivity for a breast cancer patient: a case report. Si H; Li X J Nucl Med Technol; 2012 Jun; 40(2):89-91. PubMed ID: 22505488 [TBL] [Abstract][Full Text] [Related]
20. Tc-99m MIBI filling pattern in a photopenic area of a Tc-99m MDP scan in a patient with metastatic bone involvement of breast carcinoma. Durmus Altun G; Uzal C; Hacimahmutoglu S; Pekindil G; Sarikaya A; Omer Yigitbasi N Clin Nucl Med; 2002 May; 27(5):381-2. PubMed ID: 11953584 [No Abstract] [Full Text] [Related] [Next] [New Search]